Download App  |   SIP Calculator   |   News & Blogs

New Fund Offers (NFO)

Invest in the latest NFOs to build wealth for long term.
Apply Cancel
Methodology of choosing Funds

All the NFOs of top AMCs in India are listed under this section to deliver you the utmost convenience of choosing the suitable one at a single place. Evaluate each NFO carefully to see whether it's worthy of your portfolio or not and make a smart investment decision. Check for Open, Upcoming, and Closed NFOs at a glance.

  • Open Funds
  • Upcoming
  • Closed
Filter Fund by
NFO Name Category Open Close Days Left Min. Inv. Amount Action
SBI Long Term Advantage Fund Series VI - Regular Plan (G)
SBI Long Term Advantage Fund Series VI - Regular Plan (G)
  • Tenure (Days): 3650
    Riskometer : Moderately High
  • Benchmark : S&P BSE 500 Index
    Fund Manager : Mr. Anup Upadhyay
Suitability

This Product is suitable for investors who are seeking :-

1. Capital appreciation over a period of 10 years.

2. Investment in equity and equity related instruments of companies along with income tax benefit u/s 80C of the Income Tax Act, 1961.

Key Highlights :

1. The fund investment strategy is split into three parts; Asset Allocation, Top-down approach, & Bottom-up approach. SBI Long Term Advantage Fund Series – VI is long term equity strategy, the portfolio would be constructed using combination of all the above segments.

 		ELSS 11-Apr-18 10-Jul-18
19
500

Invest Now
Mirae Asset Healthcare Fund (G)
Mirae Asset Healthcare Fund (G)
  • Tenure (Days): 365
    Riskometer : High
  • Benchmark : S&P BSE Healthcare
    Fund Manager : Neelesh Surana since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

1. To generate long-term capital appreciation.

2. Investment in equities and equity-related securities of companies benefiting directly or indirectly in Healthcare & Allied sectors in India.

Key Highlights :

1. Atleast 80% investments in Pharma, Healthcare and allied sectors.

2. Fundamental, bottom-up approach that aims to identify growth companies with high return ratios (ROE) and sustainable competitive advantage.

3. Flexibility to invest across market capitalization and style in selecting investment opportunities within this theme

4. Endeavour to maintain a concentrated portfolio of 30 – 40 stocks.

 		Sector - Pharma & Healthcare 11-Jun-18 25-Jun-18
4
5000

Invest Now
Sundaram Multi Cap Series 1 (G)
Sundaram Multi Cap Series 1 (G)
  • Tenure (Days): 1825
    Riskometer : Moderately High
  • Benchmark : S&P BSE 500 TRI
    Fund Manager : Dwijendra Srivastava since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

1. Long-term investment.

2. A close-ended equity fund that aims to generate capital appreciation.

Key Highlights :

1. The scheme aims to provide long term capital growth by investing in a well-diversified portfolio of equity and equity related securities across market capitalisation and sectors.

2. To reduce the risk of the portfolio, the Scheme may also use various derivative and hedging products from time to time for hedging and rebalancing purposes, in the manner permitted by SEBI.

 		Multi Cap 08-Jun-18 22-Jun-18
1
5000

Invest Now
Reliance Nivesh Lakshya Fund (G)
Reliance Nivesh Lakshya Fund (G)
  • Tenure (Days): 365
    Riskometer : Moderate
  • Benchmark : CRISIL Long Term Debt
    Fund Manager : Kinjal Desai since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Debt Long Term 18-Jun-18 02-Jul-18
11
5000

Invest Now
ICICI Prudential BHARAT 22 FOF (G)
ICICI Prudential BHARAT 22 FOF (G)
  • Tenure (Days): 365
    Riskometer : High
  • Benchmark : S&P BSE Bharat 22 TRI
    Fund Manager : Kayzad Eghlim since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Multi Cap 19-Jun-18 22-Jun-18
1
5000

Invest Now
Invesco India Equity & Bond Fund - Regular Plan (G)
Invesco India Equity & Bond Fund - Regular Plan (G)
  • Tenure (Days): 365
    Riskometer : Moderately High
  • Benchmark : CRISIL Hybrid 35+65 Aggressive
    Fund Manager : Amit Ganatra since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Equity Oriented Hybrid Speciality 11-Jun-18 25-Jun-18
4
5000

Invest Now
Reliance Nivesh Lakshya Fund (DR)
Reliance Nivesh Lakshya Fund (DR)
  • Tenure (Days): 365
    Riskometer : Moderate
  • Benchmark : CRISIL Long Term Debt
    Fund Manager : Kinjal Desai since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Debt Long Term 18-Jun-18 02-Jul-18
11
5000

Invest Now
SBI Long Term Advantage Fund Series VI - Regular Plan (D)
SBI Long Term Advantage Fund Series VI - Regular Plan (D)
  • Tenure (Days): 3650
    Riskometer : Moderately High
  • Benchmark : S&P BSE 500 Index
    Fund Manager : Mr. Anup Upadhyay
Suitability

This Product is suitable for investors who are seeking :-

1. Capital appreciation over a period of 10 years.

2. Investment in equity and equity related instruments of companies along with income tax benefit u/s 80C of the Income Tax Act, 1961.

Key Highlights :

1. The fund investment strategy is split into three parts; Asset Allocation, Top-down approach, & Bottom-up approach. SBI Long Term Advantage Fund Series – VI is long term equity strategy, the portfolio would be constructed using combination of all the above segments.

 		ELSS 11-Apr-18 10-Jul-18
19
500

Invest Now
Mirae Asset Healthcare Fund (D)
Mirae Asset Healthcare Fund (D)
  • Tenure (Days): 365
    Riskometer : High
  • Benchmark : S&P BSE Healthcare
    Fund Manager : Neelesh Surana since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

1. To generate long-term capital appreciation.

2. Investment in equities and equity-related securities of companies benefiting directly or indirectly in Healthcare & Allied sectors in India.

Key Highlights :

1. Atleast 80% investments in Pharma, Healthcare and allied sectors.

2. Fundamental, bottom-up approach that aims to identify growth companies with high return ratios (ROE) and sustainable competitive advantage.

3. Flexibility to invest across market capitalization and style in selecting investment opportunities within this theme

4. Endeavour to maintain a concentrated portfolio of 30 – 40 stocks.

 		Sector - Pharma & Healthcare 11-Jun-18 25-Jun-18
4
5000

Invest Now
Sundaram Multi Cap Series 1 (D)
Sundaram Multi Cap Series 1 (D)
  • Tenure (Days): 1825
    Riskometer : Average
  • Benchmark : S&P BSE 500 TRI
    Fund Manager : Dwijendra Srivastava since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

1. Long-term investment.

2. A close-ended equity fund that aims to generate capital appreciation.

Key Highlights :

1. The scheme aims to provide long term capital growth by investing in a well-diversified portfolio of equity and equity related securities across market capitalisation and sectors.

2. To reduce the risk of the portfolio, the Scheme may also use various derivative and hedging products from time to time for hedging and rebalancing purposes, in the manner permitted by SEBI.

 		Multi Cap 08-Jun-18 22-Jun-18
1
5000

Invest Now
Reliance Nivesh Lakshya Fund (D)
Reliance Nivesh Lakshya Fund (D)
  • Tenure (Days): 365
    Riskometer : Moderate
  • Benchmark : CRISIL Long Term Debt
    Fund Manager : Kinjal Desai since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Debt Long Term 18-Jun-18 02-Jul-18
11
5000

Invest Now
Invesco India Equity & Bond Fund - Regular Plan (D)
Invesco India Equity & Bond Fund - Regular Plan (D)
  • Tenure (Days): 365
    Riskometer : Moderately High
  • Benchmark : CRISIL Hybrid 35+65 Aggressive
    Fund Manager : Amit Ganatra since Jun 2018
Suitability

This Product is suitable for investors who are seeking :-

Key Highlights :
 		Equity Oriented Hybrid Speciality 11-Jun-18 25-Jun-18
4
5000

Invest Now